ArticleBMC medical imaging2026
Deep residual network fusing CT images and clinical variables to predict lung adenocarcinoma aggressiveness.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLung adenocarcinoma presenting as ground-glass nodules (GGNs) comprises three invasive subtypes (adenocarcinoma in situ [AIS], minimally invasive adenocarcinoma [MIA], invasive adenocarcinoma [IAC]) with distinct prognoses and management strategies. Preoperative discrimination of these subtypes remains challenging for radiologists, and existing deep learning models rarely integrate multi-modal data for reliable prediction. PURPOSE: This study aimed to develop and internally validate a multi-modal fusion framework based on the standard ResNet50 architecture, integrating CT images, clinical variables, and tumor markers, to improve the preoperative prediction of ground-glass nodule invasiveness.
methodsA retrospective study was conducted including 431 patients with pathologically confirmed ground-glass nodules. All patients underwent standard chest computed tomography before surgery. A multi-modal deep learning model was constructed based on the ResNet50 network, combined with clinical characteristics and laboratory indicators. Model performance was evaluated using accuracy, area under the receiver operating characteristic curve, precision, recall, and F1-score with five-fold cross-validation.
resultsThe proposed multi-modal model achieved an overall accuracy of 72.2%, precision of 95.6%, negative predictive value of 96.0%, weighted F1-score of 40.0%, and multiclass Matthews correlation coefficient of 73.1% in the three-class classification of AIS, MIA, and IAC. Per-class analysis showed precision of 84.6%, 35.7%, and 84.4% and recall of 57.9%, 29.4%, and 81.8% for AIS, MIA, and IAC, respectively. The fusion model yielded a macro-average AUC of 0.87, which was higher than the CT-only model (0.79) and both the senior (0.67) and junior radiologists (0.57). The model demonstrated superior diagnostic performance compared to human readers, particularly for the challenging MIA subtype.
conclusionThis multi-modal deep learning model combining CT images, clinical variables, and serum tumor markers enables accurate and robust three-class classification of AIS, MIA, and IAC in ground-glass nodules. The proposed model outperforms both human radiologists and the imaging-only model, suggesting its potential as a reliable auxiliary tool to improve preoperative prediction of lung adenocarcinoma invasiveness and assist clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.